Microarray gene expression profiling reveals potential mechanisms of tumor suppression by the class I HDAC-selective benzoylhydrazide inhibitors

Histone deacetylase (HDAC) inhibitors (HDIs) have therapeutic potentials for treating cancer and other diseases. Modulation of gene expression by HDIs is a major mechanism underlying their therapeutic effects. A novel class of HDIs with a previously undescribed benzoylhydrazide scaffold has been dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmud, Iqbal, Liao, Daiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Data in Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513360/
https://www.ncbi.nlm.nih.gov/pubmed/26217556
http://dx.doi.org/10.1016/j.gdata.2015.06.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513360/
https://www.ncbi.nlm.nih.gov/pubmed/26217556
http://dx.doi.org/10.1016/j.gdata.2015.06.019

Ejemplares similares